Please note: AABB reserves the right to make updates to this program.
Thursday, October 25, 2018
2:00 – 3:00 PM (ET) 7:00 – 8:00 PM (GMT)
Master Program Number: 18EL-373 (see program format numbers below under Registration)
Educational Track: Technical/Clinical
Topic: Patient Blood Management
Intended Audience: Director, Hospital Staff, Hospital Blood Banks, Laboratory Staff, Managers/Supervisors, Medical Directors, Nurses, Perfusionists, Physicians, Resident/Fellow, Technologists, Transfusion Safety Officer
Teaching Level: Intermediate to Advanced
Director/Moderator: Daryl Kor, MD, Mayo Clinic, Rochester, MN
Speaker: Martin D. Zielinski, MD, Professor of Surgery, Division of Trauma, Critical Care, and General Surgery, Medical Director for Research, Mayo Clinic Adult and Pediatric Trauma Centers, Mayo Clinic, Rochester, MN
After participating in this educational activity, participants should be able to:
- Briefly describe the history of whole blood use for the massive hemorrhaging patient in the military and civilian settings.
- Discuss the rationale for use of stored whole blood versus the individual blood components for trauma resuscitation and evidence for support of use of whole blood.
- Identify logistic concerns that need to be considered for manufacturing and supplying universal group O whole blood for trauma resuscitation.
What is the optimal blood product for life threatening bleeding in trauma patients? The current practice of transfusion of packed red cells, plasma, and platelets in a 1:1:1 or 2:1:1 ratio has shown to improve morbidity and mortality. However, recent focus has been on the transfusion of stored whole blood for trauma resuscitation. In this eCast the history of whole blood use and its resurgence as a treatment modality for trauma patients will be discussed as well as logistics to manufacture whole blood.
| || ||
|Single Viewer: Live||
|Single Viewer: On-Demand||
|Group Viewing: Live||
|Group Viewing: On-Demand||
|Group Viewing: Live & On-Demand||